Skip to main content
Premium Trial:

Request an Annual Quote

UK Genomics Research Startup Sano Genetics Raises £500K

NEW YORK (GenomeWeb) — UK genomic research and data-sharing startup Sano Genetics has raised £500,000 ($653,615) in seed financing, the company said today.

The funding was provided by Seedcamp and Cambridge Enterprise, as well as a number of individual investors.

Cambridge-based Sano said it will use the money to support its data-sharing platform, through which individuals can submit their medical history and available genetic data, and be matched with studies that could benefit from the information. The company noted that it works to match participants with research projects that offer cost-free genome sequencing. In exchange, participants receive free personalized health and wellness reports based on their genetic profiles.

Sano — formerly known as Heterogeneous — said it aims to enroll over 10,000 participants to support six new research projects by the end of 2019.

"Our platform allows scientists to do research into personalized medicine and access dynamic health and genetic data sets, while still giving individuals transparency and control throughout the process," Sano CEO Patrick Short said in a statement. "When people trust in the system and see the benefits from their participation, they are more likely to take part again in the future."

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.